TRIESENCE Drug Patent Profile
✉ Email this page to a colleague
When do Triesence patents expire, and when can generic versions of Triesence launch?
Triesence is a drug marketed by Harrow Eye and is included in one NDA. There are two patents protecting this drug.
This drug has twenty-five patent family members in twenty-one countries.
The generic ingredient in TRIESENCE is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Triesence
A generic version of TRIESENCE was approved as triamcinolone acetonide by TARO on October 1st, 1986.
Summary for TRIESENCE
International Patents: | 25 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 82 |
Clinical Trials: | 10 |
Patent Applications: | 3,459 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for TRIESENCE |
What excipients (inactive ingredients) are in TRIESENCE? | TRIESENCE excipients list |
DailyMed Link: | TRIESENCE at DailyMed |
Recent Clinical Trials for TRIESENCE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Oxular Limited | Phase 2 |
Wake Forest University Health Sciences | Phase 4 |
Duke University | N/A |
Pharmacology for TRIESENCE
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for TRIESENCE
US Patents and Regulatory Information for TRIESENCE
TRIESENCE is protected by three US patents.
Patents protecting TRIESENCE
Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: VISUALIZATION DURING VITRECTOMY PROCEDURES
Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF OPHTHALMIC DISORDERS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Harrow Eye | TRIESENCE | triamcinolone acetonide | INJECTABLE;INTRAVITREAL | 022048-001 | Nov 29, 2007 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Harrow Eye | TRIESENCE | triamcinolone acetonide | INJECTABLE;INTRAVITREAL | 022048-001 | Nov 29, 2007 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TRIESENCE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Harrow Eye | TRIESENCE | triamcinolone acetonide | INJECTABLE;INTRAVITREAL | 022048-001 | Nov 29, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TRIESENCE
See the table below for patents covering TRIESENCE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Mexico | 2010009974 | SUSPENSIONES DE ACETONIDA DE TRIAMCINOLONA DE BAJA VISCOSIDAD, ALTAMENTE FLOCULADAS PARA INYECCION INTRAVITREA. (LOW VISCOSITY, HIGHLY FLOCCULATED TRIAMCINOLONE ACETONIDE SUSPENSIONS FOR INTRAVITREAL INJECTION.) | ⤷ Try a Trial |
Russian Federation | 2481842 | НИЗКОВЯЗКИЕ ВЫСОКОФЛОКУЛИРОВАННЫЕ СУСПЕНЗИИ ТРИАМЦИНОЛОНА АЦЕТОНИДА ДЛЯ ИНТРАВИТРЕАЛЬНЫХ ИНЪЕКЦИЙ (LOW-VISCOUS HIGHLY FLOCCULATED TRIAMCINOLONE ACETONIDE SUSPENSIONS FOR INTRAVITREAL INJECTIONS) | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2009114521 | ⤷ Try a Trial | |
Chile | 2009000573 | Composicion farmaceutica inyectable intraocular en forma de suspension acuosa que no contiene preservante, que consiste de acetonido de triamcinolona, carboximetilcelulosa de sodio, 0,002-0,02% de polisorbato 80, cloruros para ajustar la tonicidad, agente tamponante, agua y agente de ajuste de ph; uso para tratar el ojo. | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |